Dr. Lal Pathlabs Peer Comparison
NSE: LALPATHLAB | BSE: 539524
₹1,971.30
₹-33.80
(-1.69%)
As on 05-Oct-2026 15:54IST
Market cap
₹33,108 Cr
Revenue (TTM)
₹2,891 Cr
P/E Ratio
61.1
P/B Ratio
12.7
Div. Yield
1 %
Edit
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
33,108 | 35,795 | 29,613 | 14,595 | 11,430 |
Revenue (₹ Cr) |
2,891 | 4,683 | 4,213 | 857 | 1,710 |
Net Profit (₹ Cr) |
546.30 | 552.34 | 190.80 | 187.49 | 202.82 |
Net Margin (%) |
18.23 | 11.55 | 4.49 | 21.32 | 11.70 |
RoE (%) |
23.03 | 14.93 | 9.45 | 20.58 | 14.13 |
Price to Earnings |
61.10 | 64.36 | 144.95 | 77.84 | 56.69 |
Price-To-Book |
12.67 | 8.70 | 7.83 | 14.49 | 7.33 |
Income Statement (₹ Cr)
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2,890.80 | 4,683.37 | 4,212.50 | 857.13 | 1,710.00 |
|
Total Income
|
2,995.90 | 4,783.78 | 4,248.00 | 879.41 | 1,733.17 |
|
Total Expenditure
|
2,053.10 | 3,704.62 | 3,379.70 | 495.19 | 1,287.72 |
|
EBITDA
|
837.70 | 978.75 | 832.80 | 361.94 | 422.28 |
|
Depreciation
|
171.60 | 246.41 | 330.60 | 96.06 | 135.28 |
|
EBIT
|
666.10 | 732.34 | 502.20 | 265.89 | 287.00 |
|
Interest
|
24.40 | 92.01 | 253.30 | 36.75 | 25.53 |
|
Other Income
|
105.10 | 100.41 | 35.50 | 22.28 | 23.17 |
|
Exceptional Items
|
-30.10 | -20.61 | -11.20 | 0.00 | -8.99 |
|
Profit before Tax
|
716.70 | 720.14 | 273.20 | 251.42 | 275.66 |
|
Provision for Tax
|
170.40 | 167.80 | 82.40 | 63.93 | 72.84 |
|
Profit after Tax
|
546.30 | 552.34 | 190.80 | 187.49 | 202.82 |
Liabilities (₹ Cr)
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,508.20 | 3,961.57 | 2,247.40 | 957.15 | 1,513.16 |
|
Minority Interest
|
-4.40 | 3.84 | 9.90 | 0.00 | -1.20 |
|
Non-Current Liabilities
|
154.00 | 1,293.60 | 3,961.30 | 426.03 | 279.48 |
|
Current Liabilities
|
450.70 | 627.13 | 1,238.90 | 123.87 | 334.02 |
|
Total Liabilities
|
3,139.97 | 5,905.00 | 7,690.70 | 1,507.05 | 2,524.76 |
Assets (₹ Cr)
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,176.30 | 3,128.95 | 5,416.90 | 737.24 | 1,415.30 |
|
Current Assets
|
1,566.60 | 1,674.92 | 937.40 | 321.90 | 468.61 |
|
Total Assets
|
3,139.97 | 5,905.00 | 7,690.70 | 1,507.05 | 2,524.76 |
|
Total Debt*
|
0.00 | 631.08 | 3,244.00 | 0.00 | 18.73 |
|
Net Current Assets
|
1,115.90 | 1,047.79 | -301.50 | 198.03 | 134.59 |
|
Contingent Liabilities
|
16.76 | 100.01 | 81.10 | 0.13 | 10.08 |
Cashflow (₹ Cr)
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
635.61 | 714.39 | 510.80 | 270.59 | 350.70 |
|
Cash Flow from Investing Activities
|
-421.86 | -1,089.11 | -1,451.70 | -174.22 | -223.13 |
|
Cash from Financing Activities
|
-263.57 | 271.85 | 940.30 | -69.49 | -115.29 |
|
Net Cash Inflow / Outflow
|
-49.83 | -102.87 | -0.60 | 26.88 | 12.28 |
Ratios
Profitability Ratios
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
ROCE (%)
|
29.56 | 19.38 | 11.51 | 30.28 | 20.03 |
|
ROE (%)
|
23.03 | 14.93 | 9.45 | 20.58 | 14.13 |
|
ROA (%)
|
18.64 | 10.35 | 2.83 | 13.49 | 10.13 |
|
EBIT Margin (%)
|
23.04 | 15.64 | 11.92 | 31.02 | 16.78 |
|
Net Margin (%)
|
18.23 | 11.55 | 4.49 | 21.32 | 11.70 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
14.29 | 21.27 | 30.90 | 20.18 | 21.80 |
|
EBIT Growth (%)
|
15.64 | 0.94 | -16.88 | 26.22 | 43.53 |
|
Net Profit Growth (%)
|
5.38 | 3.43 | -52.81 | 24.27 | 32.87 |
|
EPS Growth (%)
|
-30.51 | 2.70 | -42.60 | 23.44 | -16.64 |
|
Book Value Growth (%)
|
15.41 | 16.51 | 5.13 | 21.86 | 13.54 |
Valuation Ratios
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Price / Earnings
|
47.07 | 63.76 | 139.13 | 78.33 | 21.86 |
|
Price / Book Value
|
12.89 | 8.88 | 8.16 | 14.61 | 7.16 |
|
Dividend Yield (%)
|
1.02 | 0.04 | 0.00 | 0.14 | 0.93 |
|
EV/EBITDA
|
38.61 | 36.80 | 40.86 | 39.87 | 25.99 |
|
Market Cap (₹ Cr)
|
22,015.15 | 25,841.07 | 24,901.98 | 8,864.05 | 8,992.90 |
Solvency Ratios
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.15 | 1.19 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
-- | -- | 0.15 | -- | 0.01 |
|
Current Ratio
|
3.48 | 2.67 | 0.76 | 2.60 | 1.40 |
|
Quick Ratio
|
3.38 | 2.54 | 0.68 | 2.56 | 1.27 |
|
Interest Coverage
|
30.37 | 8.83 | 2.08 | 7.84 | 11.80 |
Operating Efficiency Ratios
| Dr. Lal Pathlabs | Global Health | Krishna Institute | Vijaya Diagno | Metropolis Health | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
3.83 | 8.78 | 13.16 | 2.43 | 9.96 |
|
Asset Turnover
|
0.99 | 0.88 | 0.62 | 0.62 | 0.85 |
|
Receivable days
|
13.13 | 29.09 | 44.38 | 7.98 | 35.29 |
|
Inventory Days
|
5.28 | 6.05 | 7.52 | 2.20 | 10.35 |
|
Payable days
|
118.67 | 80.04 | 133.54 | 136.27 | 143.56 |
|
Cash Conversion Cycle
|
-100.26 | -44.90 | -81.64 | -126.08 | -97.92 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
